Inspire Medical Systems (STU:2DR) LT-Debt-to-Total-Asset : 0.04 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Inspire Medical Systems LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Inspire Medical Systems's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.04.

Inspire Medical Systems's long-term debt to total assets ratio increased from Mar. 2023 (0.01) to Mar. 2024 (0.04). It may suggest that Inspire Medical Systems is progressively becoming more dependent on debt to grow their business.

Inspire Medical Systems LT-Debt-to-Total-Asset Historical Data

The historical data trend for Inspire Medical Systems's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspire Medical Systems LT-Debt-to-Total-Asset Chart

Inspire Medical Systems Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.14

0.11

0.08

0.01

0.04

Inspire Medical Systems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.04	0.04	0.04	0.04

Inspire Medical Systems LT-Debt-to-Total-Asset Calculation

Inspire Medical Systems's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	22.784	/	620.636
	=	0.04

Inspire Medical Systems's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	22.54	/	630.975
	=	0.04

Inspire Medical Systems (STU:2DR) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Inspire Medical Systems LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Inspire Medical Systems (STU:2DR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (STU:2DR) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

INSP:USA 2DR:Germany

Address

5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416

Website

https://www.inspiresleep.com

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Inspire Medical Systems (STU:2DR) Headlines

No Headlines